The Qsymia REMS program is intended to help prevent:

Rationale

The Qsymia REMS program is intended to help prevent embryo-fetal exposure.

The Qsymia REMS (Risk Evaluation and Mitigation Strategy) program is specifically designed to mitigate the risk of embryo-fetal exposure to the medication, which can lead to serious birth defects if taken during pregnancy.

A (embryo-fetal exposure.) CORRECT

This choice is correct because the primary focus of the Qsymia REMS program is to prevent potential harm to a developing fetus caused by the teratogenic effects of the medication. The program includes guidelines for prescribing and distributing Qsymia to ensure that women of childbearing potential are aware of these risks and can take appropriate precautions.

B (respiratory depression.) YOUR ANSWER

While respiratory depression is a potential side effect of some medications, it is not the main concern addressed by the Qsymia REMS program. The program is not focused on respiratory issues but rather on preventing exposure during pregnancy, making this choice incorrect.

C (fatal hemorrhage.) YOUR ANSWER

Fatal hemorrhage is not a known risk associated with Qsymia and is not a focus of the REMS program. This choice misrepresents the intent of the program, which is concentrated on pregnancy-related risks rather than hemorrhagic complications.

D (vision loss.) YOUR ANSWER

Vision loss is also not a primary concern related to Qsymia, and the REMS program does not specifically address this issue. This choice does not reflect the purpose of the program, which is to prevent risks associated with embryo-fetal exposure.

Conclusion

The Qsymia REMS program is crucial for preventing embryo-fetal exposure due to the serious risks posed by the medication during pregnancy. By focusing on this specific concern, the program aims to ensure that women who are pregnant or may become pregnant are adequately informed and protected. The other options do not align with the primary objectives of the REMS program, reinforcing the importance of targeted risk management in medication use.

The Qsymia REMS program is intended to help prevent:

The Qsymia REMS program is intended to help prevent embryo-fetal exposure.

Related Questions

Related Quizzes

How familiar were you with this question?

Report an Issue

Rate this Practice Test